About
Epizyme, Inc. is a clinical-stage biopharmaceutical company developing novel epigenetic medicines to treat cancer and other serious diseases.
Explore Epizyme, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.